GTC Biotherapeutics News

LEXINGTON, Mass. -- -- AMAG Pharmaceuticals, Inc. today announced the appointment of William K. Heiden as president and chief executive officer, effective May 14, 2012.

Joann White production parlor supervisor at GTC Biotherapeutics' farm in Charlton prepares to milk a goat.

Texas A&M researcher Charles R. Long holds a female goat that is genetically modified to produce a malaria vaccine in it's milk at the The Reproductive Sciences Complex Tuesday, Jan.

TG Therapeutics, Inc. - announced today an agreement with two LFB Group companies, LFB Biotechnologies S.A.S and GTC Biotherapeutics, Inc., to license the worldwide commercial rights to Ublituximab, a novel, third generation chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen found on B lymphocytes.